18 March 2024: Clinical Research
Association of T Cell Subsets and Platelet/Lymphocyte Ratio with Long-Term Complications in Kidney Transplant Recipients
Yun Yang 1ABCDEFG , Jie-Hui Chen 1BCDE , Shu-Xiao Zhang 1BCDE , Sheng-Lang Zhu 1ADEF* , Heng-Mei Zhu 12AEFG*DOI: 10.12659/MSM.942324
Med Sci Monit 2024; 30:e942324
Table 1 Comparison of general clinical data, between the non-infected group and the infected group of kidney transplant recipients.
| Indexes | Total | Non-infected group | Infected group | P value | χ2/t/Z |
|---|---|---|---|---|---|
| n [%] | 271 | 107 (39.48%) | 164 (60.52%) | – | – |
| CKD S1 | 46 | 18 (39.13%) | 28 (60.87%) | 0.926 | 0.892 |
| CKD S2 | 83 | 35 (42.17%) | 48 (57.83%) | ||
| CKD S3 | 85 | 31 (36.47%) | 54 (63.53%) | ||
| CKD S4 | 34 | 15 (44.12%) | 21 (55.88%) | ||
| CKD S5 | 19 | 8 (42.11%) | 12 (57.89%) | ||
| Sex (Male/Female) | 170/101 | 76/31 | 94/70 | 0.015* | 5.594 |
| Age (years) | 44 (37–53) | 45.5 (38–55) | 43 (37–52) | 0.389 | −0.862 |
| KT time(years) | 6 (2.75–10.25) | 7 (3.06–10.36) | 5 (2.17–10.29) | 0.159 | −1.410 |
| Hb(g/L) | 118.98±25.12 | 120.30±29.09 | 118.14±22.27 | 0.365 | 0.908 |
| ALB(g/L) | 38.04±4.66 | 38.69±5.02 | 37.62±4.38 | 0.077 | 1.773 |
| UA (mmol/L) | 390.70±111.22 | 419.66±111.79 | 372.15±107.16 | 0.001* | 3.317 |
| Cr (μmol/L) | 114.8 (80.6–169.3) | 124.35 (82.9–189.2) | 108.9 (78.8–156) | 0.395 | −0.851 |
| GFR (mL/min) | 58.72±30.32 | 57.55±32.25 | 59.47±29.10 | 0.874 | −0.158 |
| ALB – albumin; CD – cluster of differentiation; CKD S1 –chronic kidney disease stage 1; CKD S2 –chronic kidney disease stage 2; CKD S3 – chronic kidney disease stage 3; CKD S4 – chronic kidney disease stage4; CKD S5 – chronic kidney disease stage 5; Cr – creatinine; Hb – hemoglobin; KT – kidney transplantation; UA – uric acid, GFR – glomerular filtration rate. * | |||||